Resonance Health Akcija

Resonance Health EV/FCF

Resonance Health (RHT.AX) EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) 2026-08-18 dieną yra 33,95. Praėjusiais metais EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) buvo 17,09 — pokytis 98,72% (didesnis).

EV/FCF

33,95

YoY

98,72%

Paskutinį kartą atnaujinta:

Resonance Health EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) yra 2026 33,95 . Resonance Health EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) buvo 2025 17,09 . Tai sumažėjo 98,72% didesnis lyginant su praėjusiais metais.
Access this data via the Eulerpool API

Resonance Health Akcijų analizė

Ką veikia Resonance Health? Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health yra viena populiariausių kompanijų Eulerpool.com.

Dažniausiai užduodami klausimai apie Resonance Health akciją

Resonance Health EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) 2026 m. yra 33,95.

Resonance Health EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) pasikeitė nuo 17,09 iki 33,95, tai atitinka 98,72% pokytį. Reikšmė yra didesnis nei praėjusiais metais.

Eulerpool rasite visą EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) Resonance Health istorinę raidą nuo 2006 m. – su metinėmis reikšmėmis, grafikais ir išsamiomis analizėmis.

EV/FCF santykis matuoja įmonės vertę, palyginti su laisvuoju pinigų srautu, ir parodo tikrąją įmonės gebą generuoti grynąjį pinigų srautą.

Norėdami įvertinti EV/FCF (Įmonės vertė pagal laisvą pinigų srautą), svarbu jį palyginti su toje pačioje pramonėje veikiančiais konkurentais. Eulerpool platformoje galite rasti tiesioginius pramonės palyginimus EV/FCF (Įmonės vertė pagal laisvą pinigų srautą).

"Geras" skiriasi priklausomai nuo pramonės šakos ir įmonės etapo. Eulerpool platformoje galite palyginti EV/FCF (Įmonės vertė pagal laisvą pinigų srautą) Resonance Health su sektoriaus konkurentais ir pramonės vidurkiu, kad įvertintumėte jo patrauklumą.

Access this data via the Eulerpool API

Vertinimas — Resonance Health

Visi pagrindiniai rodikliai — Resonance Health